Discontinuation report PRADAXA
Report ID | 34114 |
Drug Identification Number | 02312441 |
Brand name | PRADAXA |
Common or Proper name | Pradaxa Bottles 60's |
Company Name | BOEHRINGER INGELHEIM (CANADA) LTD LTEE |
Market Status | MARKETED |
Active Ingredient(s) | DABIGATRAN ETEXILATE |
Strength(s) | 110MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | Pradaxa 110mg 60s (Bottle) |
ATC code | B01AE |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2017-12-19 |
Actual discontinuation date | 2017-12-19 |
Remaining supply date | 2017-12-19 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | 110mg 6x10 BLISTER PACKS REMAIN AVAILABLE |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 5180 SOUTH SERVICE ROAD BURLINGTON, ONTARIO CANADA L7L 5H4 |
Company contact information | 1800 263 2425 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-12-21 | English | Compare |
v2 | 2017-12-21 | French | Compare |
Showing 1 to 2 of 2